OQROSign up free
Politician trade (Senate)

Pfizer (PFE): Sen. Tommy Tuberville disclosed a purchase $1K–$15K

Sen. Tommy Tuberville disclosed a purchase of Pfizer in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
32 days
Disclosure lag
Traded
Jun 12, 2023
Disclosed
Jul 14, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 15, 2021CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
  2. Mar 3, 2023CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  3. Mar 6, 2023CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
  4. Mar 7, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  5. Mar 14, 2023CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  6. Apr 10, 2023CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  7. Apr 28, 2023CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  8. May 26, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  9. Jun 12, 2023 · this disclosureCongressDisclosed purchase of PFE — reported range $1,001 - $15,000

What came next

  1. Jun 28, 2023CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  2. Jul 12, 2023CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  3. Jul 25, 2023CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
  4. Sep 8, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  5. Oct 2, 2023FDARecall: 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Ho…
  6. Oct 2, 2023FDARecall: 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospir…
  7. Oct 2, 2023FDARecall: 1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hos…
  8. Oct 4, 2023FDAFDA drug approval: Abrilada
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Pfizer

OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Sen. Tommy Tuberville

The full history of Sen. Tommy Tuberville is on the profile page.

How this filing works

Explore the data

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data